Lipocine Inc. (LPCN) Social Stream
LIPOCINE INC (LPCN) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering LIPOCINE INC.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-12 | 3 | $6 | $2.5 | $3.75 | $0.52 | 621.15% |
2022-05-10 | 2 | $6 | $2.5 | $3.75 | $0.52 | 621.15% |
2022-05-20 | 2 | $5.5 | $2.5 | $3.625 | $0.52 | 597.12% |
2022-08-10 | 2 | $5.5 | $2 | $3.375 | $0.52 | 549.04% |
2022-11-10 | 2 | $5.5 | $2 | $3.833 | $0.52 | 637.12% |
The Trend in the Analyst Price Target
LPCN's average price target has moved down $2 over the prior 21 months.
Over the past 35 weeks, LPCN's average upside potential has been 446.28%.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2022-05-10 | 2 | 5.5 | 2.5 | 3.625 | 0.760 | 376.97% |
2022-05-10 | 2 | 6.0 | 2.5 | 3.750 | 0.760 | 393.42% |
2022-05-20 | 2 | 5.5 | 2.5 | 3.625 | 0.904 | 301% |
2022-08-10 | 2 | 5.5 | 2.0 | 3.333 | 0.712 | 368.12% |
2022-11-10 | 2 | 5.5 | 2.0 | 3.333 | 0.379 | 779.42% |
LPCN Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
LPCN's average broker recommendation rating improved by 0 over the prior 26 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LPCN as an investment opportunity.
- In terms of how LIPOCINE INC fares relative to all US stocks, note that its average analyst price target is higher than 12.18% of that group.
- In terms of how LIPOCINE INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 25.9% of that group.
- In terms of how LIPOCINE INC fares relative to stocks in the small market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 515.81% of that group.
- LPCN has a lower variance in analysts' estimates than -396.39% of stocks in the small market cap category.
Stocks similar to LIPOCINE INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are VSTM, RGLS, and KPTI.
View All Top Stocks by Price Target
What is the outlook for LPCN? Use POWR Ratings for clearer insight into price direction.